Recent literature also suggests that Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) transcription factor plays a role in the pathogenesis and progression of gliomas with IDH mutations [10]. This evidence concerns the gene NFE2L2 and central nervous system cancer.